Advertisement
U.S. Markets closed

Contineum Therapeutics, Inc. (CTNM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W
16.38-0.10 (-0.61%)
At close: 04:00PM EDT
16.38 0.00 (0.00%)
After hours: 04:01PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
50,000
0
0
Operating Expense
38,619
33,923
22,720
28,647
Operating Income
-38,619
16,077
-22,720
-28,647
Net Non Operating Interest Income Expense
7,163
4,398
373
-255
Other Income Expense
-269
2,695
-1,906
-99
Pretax Income
-31,725
23,170
-24,253
-29,001
Tax Provision
-279
450
0
-
Net Income Common Stockholders
-227
22,720
-24,253
-29,001
Diluted NI Available to Com Stockholders
2,693
22,720
-24,253
-29,001
Basic EPS
1.36
1.36
-1.45
-1.74
Diluted EPS
1.12
1.12
-1.45
-1.74
Basic Average Shares
16,674
16,674
16,674
16,674
Diluted Average Shares
17,761
17,761
17,761
17,761
Total Operating Income as Reported
-38,619
16,077
-22,720
-28,647
Total Expenses
38,619
33,923
22,720
28,647
Net Income from Continuing & Discontinued Operation
-31,446
22,720
-24,253
-29,001
Normalized Income
-31,343
19,904
-22,439
-28,993
Interest Income
7,163
4,606
761
77
Interest Expense
0
208
388
332
Net Interest Income
7,163
4,398
373
-255
EBIT
-31,725
23,378
-23,865
-28,669
EBITDA
-31,524
23,573
-23,536
-28,344
Reconciled Depreciation
201
195
329
325
Net Income from Continuing Operation Net Minority Interest
-31,446
22,720
-24,253
-29,001
Total Unusual Items Excluding Goodwill
-104
2,872
-1,814
-8
Total Unusual Items
-104
2,872
-1,814
-8
Normalized EBITDA
-31,420
20,701
-21,722
-28,336
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
-0.9146
55.779
0
0